ResearcherChinese Academy of Medical Sciences & Peking Union Medical CollegeActive in the last 2 years

Zhaoyong Yang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-7197-3991; OpenAlex author ID A5040032635. Sources: OpenAlex.

Their work

Papers: 2 (first author 0, last author 2)
Trials: 0
Grants: 0
Labs led: 1
Collaborators: 4

Papers, trials and grants by year

2022: 1 paper · 2023: none · 2024: none · 2025: 1 paper

Papers 2

MUC1 peptide-loaded dendritic cell vaccine boosts antitumor immunity in pancreatic cancer. Last author DOI 10.3389/fimmu.2025.1752861 ↗
The antitumor activity of hPRDX5 against pancreatic cancer and the possible mechanisms. Last author DOI 10.1590/1414-431x2022e12324 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Huiping Xie · 1 shared paper, 2025 · strength 0.27
- Paper MUC1 peptide-loaded dendritic cell vaccine boosts antitumor immunity in pancreatic cancer. DOI 10.3389/fimmu.2025.1752861 ↗
Wenzhuo Yang · 1 shared paper, 2025 · strength 0.27
- Paper MUC1 peptide-loaded dendritic cell vaccine boosts antitumor immunity in pancreatic cancer. DOI 10.3389/fimmu.2025.1752861 ↗
Lihua Cui · 1 shared paper, 2022 · strength 0.17
- Paper The antitumor activity of hPRDX5 against pancreatic cancer and the possible mechanisms. DOI 10.1590/1414-431x2022e12324 ↗
Jing Xun · 1 shared paper, 2022 · strength 0.17
- Paper The antitumor activity of hPRDX5 against pancreatic cancer and the possible mechanisms. DOI 10.1590/1414-431x2022e12324 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.